These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Multiple drug transporters contribute to the brain transfer of levofloxacin. Cen Y; Shan Y; Zhao J; Xu X; Nie Z; Zhang J CNS Neurosci Ther; 2023 Jan; 29(1):445-457. PubMed ID: 36253925 [TBL] [Abstract][Full Text] [Related]
44. Management of levofloxacin induced anaphylaxis and acute delirium in a palliative care setting. Ghoshal A; Damani A; Salins N; Deodhar J; Muckaden MA Indian J Palliat Care; 2015; 21(1):76-8. PubMed ID: 25709191 [TBL] [Abstract][Full Text] [Related]
45. Lack of nephrotoxic effects of the new quinolone antibacterial agent levofloxacin in rabbits. Inage F; Kato M; Yoshida M; Akahane K; Takayama S Arzneimittelforschung; 1992 Mar; 43(3A):395-7. PubMed ID: 1622439 [TBL] [Abstract][Full Text] [Related]
46. Interaction of the new quinolone antibacterial agent levofloxacin with fenbufen in mice. Furuhama K; Akahane K; Tawara K; Takayama S Arzneimittelforschung; 1992 Mar; 43(3A):406-8. PubMed ID: 1622442 [TBL] [Abstract][Full Text] [Related]
47. Acute oral toxicity of the new quinolone antibacterial agent levofloxacin in mice, rats and monkeys. Kato M; Furuhama K; Yoshida M; Akahane K; Takayama S Arzneimittelforschung; 1992 Mar; 43(3A):365-6. PubMed ID: 1622433 [TBL] [Abstract][Full Text] [Related]
48. Phototoxic potential of the new quinolone antibacterial agent levofloxacin in mice. Wagai N; Yoshida M; Takayama S Arzneimittelforschung; 1992 Mar; 43(3A):404-5. PubMed ID: 1622441 [TBL] [Abstract][Full Text] [Related]
49. Levofloxacin, a new quinolone antibacterial agent. An introductory overview. Hayakawa I; Furuhama K; Takayama S; Osada Y Arzneimittelforschung; 1992 Mar; 43(3A):363-4. PubMed ID: 1622431 [No Abstract] [Full Text] [Related]